Objective: To determine the kappa (κ) concordance coefficient between fine needle aspiration and serum prostatic antigen (PSA) coupled with digital rectal examination and prostatic ultrasound. Material and Methods: We conducted a cross-sectional study covering the period from January 1st to June 30th, 2018 in the city of Pointe-Noire. It is a study of 31 cases of prostate tumors in Congolese subjects at the General Hospital of Loandjili in Pointe-Noire of Congo Brazzaville. The clinical, biological, ultrasound and cytological aspects were the variables of the study. Results: The mean age was 71.06 years with extremes of 57 and 93 years. One patient had a family history of prostate cancer that was found at his brother’s house at the age of 52. Dysuria was the most represented sign in all of our patients. Suspicion of prostate cancer was the most commonly talked in digital rectal examination. Prostate specific antigen (PSA) was greater than or equal to 10 ng/ml in more 74% of our patients. 61.3% of our patients had a heterogeneous prostatic ultrasound. 48.3% of malignant tumors and 32.3% of benign tumors were found cytologically. The association between digital rectal examination and prostatic ultrasound was statistically significant (p ≤ 0.05) and good agreement was found between cytological diagnosis coupled with digital rectal examination and prostatic echostructure (0.6 ≤ κ ≤ 0.8). A low concordance between prostatic specific antigen (PSA) and cytological concordance was noted (0.2 ≤ κ ≤ 0.4). Conclusion: Prostatic tumors in Congo in their diagnostic particularities are dominated by malignant tumors with a large number of patients to watch. The fine needle aspiration is suitable for orientation examinations of prostatic tumors and can be performed by any doctor and provides us a fast, effective diagnostic orientation with a strong clinico-morphological correlation in our low incomes countries.
References
[1]
Richard, F., Luckas, B., Jardin, A., Lanson, Y., Chevret-Meason, M., Grange, R.J.C. and Navratil, H. (2001) Résultats d’une enquête épidémiologique menée chez les hommes agés de 50-80 ans étudiant les troubles mictionnels, qualité de vie et fonction sexuelle. Progrès en Urologie, 11, 250-263.
[2]
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R.L., Torre, L.A. and Jemal, A. (2018) Global Cancer Statistics: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 68, 394-424.
https://doi.org/10.3322/caac.21492
[3]
Tuppin, P., et al. (2012) Consommation du dosage de l’antigène spécifique de la prostate (PSA) en France chez les hommes sans cancer de la prostate déclaré. Bulletin du Cancer, 99, 521-527.
[4]
Chang, B.L., Spangler, E., Gallagher, S., et al. (2012) Validation of Genome-Wide Prostate Cancer Association in Men of African Descent. Cancer, Epidemiology, Biomarkers and Prevention, 20, 23-32.
https://doi.org/10.1158/1055-9965.EPI-10-0698
[5]
Sow, M., Nkégoum, B., Essame Oyono, J.L. and Garoua, N.A. (2006) Aspects épidémiologiques et histopathologiques des tumeurs urogénitales au Cameroun. Progrès en Urologie, 16, 36-39.
[6]
Nsonde Malanda, J., Nkoua-Mbon, J.B., Bamara, et al. (2013) Douze années de fonctionnement du régistre des cancers de Brazzaville. Bulletin du Cancer, 100, 135-139. https://doi.org/10.1684/bdc.2013.1701
[7]
(2011) Hyperplasie benigne de la prostate (HBP). http://www.urofrance.org
[8]
McKelvie, G.B., Collins, G.N., Hehir, M. and Rogers, A.C. (1993) A Study of Benign Prostatic Hyperplasia: A Challenge to British Urology. British Journal of Urology, 71, 38-42. https://doi.org/10.1111/j.1464-410X.1993.tb15877.x
[9]
Mac Farlane, G.J., Sagnier, P.P., Richard, F., Teillac, P., Botto, H. and Boyle, P. (1995) Troubles mictionnels de l’homme agé: Quels sont les symptômes qui poussent les patients à consulter? British Journal of Urology, 76, 714-718.
https://doi.org/10.1111/j.1464-410X.1995.tb00762.x
[10]
Chauvet, B., Villers, A., Davin, J.L. and Nahon, S. (2002) Actualités sur le dépistage, le diagnostic et le traitement des cancers de prostate. Bulletin du Cancer, 89, 37-45.
[11]
Punga-Maole, A.M.L., Moningo, D.M., Kayembe, P.K., Tshikuela, M.L. and Kabongo, J.M.M. (2008) Etude de dépistage du cancer de la prostate au sein d’une population d’employés d’une entreprise de Kinshasa en République Démocratique du Congo. Taux de détection et facteurs de risque nutritionnels et géographiques. Progrès en Urologie, 18, 512-518. https://doi.org/10.1016/j.purol.2008.04.009
[12]
Demura, T., Shinohara, N., Tanaka, M., et al. (1996) The Proportion of Free to Total Prostate Specific Antigen. Bulletin du Cancer, 77, 1137-1143.
https://doi.org/10.1002/(SICI)1097-0142(19960315)77:6<1137::AID-CNCR20>3.0.CO;2-1
[13]
Faryna, J. (1997) Cytoponction à l’aiguille fine de la prostate: Indications, techniques et limites. Masson, 295, 103-107.
https://doi.org/10.1016/S0338-9898(97)80299-5
[14]
De la Taille, A., et al. (1998) Détection in vitro des cellules circulaires dans le cancer de la prostate par immunocytochimie, cytométrie en flux et RT-PCR-PSA. Progrès en Urologie, 8, 1058-1064.
[15]
Lieber, M.M. (1995) Practical Clinical Utility of DNA Ploidy for Managing Patients with Prostate Carcinoma. Urology, 45, 558-562.
https://doi.org/10.1016/S0090-4295(99)80042-9
[16]
Judith, J.T., Balachandran, K., Poothiode, U. and Bhat, S. (2014) Validity of Fine Needle Aspiration in Diagnosis of Prostatic Lesions and Correlation with Trucut Biopsy. Medical Sciences, 7, 75-80.
[17]
Al-Nasiri, U.S., Hamoodi, A.H. and Raghib, J.H. (2014) Value of Fine Needle Aspiration Cytology under Ultra-Sound Guided Biopsy in the Diagnosis of Prostatic Cancer. The Iraqi Postgraduate Medical Journal, 13, 384-389.
[18]
Saleh, A.F.M., Nahar Rahman, A.J.E., Salam, M.A. and Islam, F. (2005) Role of Fine Needle Aspiration Cytology (FNAC) in the Diagnosis of Prostatic Lesions with Histologic Correlation. Bangladesh Medical Research Council Bulletin, 31, 95-103.
[19]
Tariqul, I., Tamanna, C., Khan, K.H., Barua, A.R., Mohammed, K. and Nahar Rahman, A.J.E. (2007) Fine Needle Aspiration Cytology of Prostatic Lesions with Histologic Correlation. Ibrahim Medical College Journal, 1, 7-10.
https://doi.org/10.3329/imcj.v1i1.2888
[20]
Chayanika, P., Sanjay, K., Singh, P.K., Asha, A. and Sonal, A. (2012) A Correlative Study between Transrectal FNAC and Histology of the Prostate for the Detection of Prostate Carcinoma. IOSR Journal of Dental and Medical Sciences, 1, 18-20.
https://doi.org/10.9790/0853-0111820
[21]
Engelstein, D., Makumel, E., Cytron, S. and Konichzky, S. (1994) A Comparison between Digitally-Guided Fine Needle Aspiration and Ultrasound-Guided Transpérinéale Core Needle Biopsy of the Prostate for the Detection of Prostate Cancer. British Journal of Urology, 74, 210-213.
https://doi.org/10.1111/j.1464-410X.1994.tb16588.x
[22]
Piaton, E. (1994) La cyto-aspiration prostatique transrectale. Andrologie, 4, 223-227.
https://doi.org/10.1007/BF03034289
[23]
Ito, H., Yamaguchi, K., Kotake, T., Metsuzaki, O. and Nagao, K. (1995) Usefulness of Aspiration Cytology in Prostate Cancer Detection. International Urology and Nephrology, 27, 93-100. https://doi.org/10.1007/BF02575226
[24]
Norming, U., Gustafsson, O., Nymant, C.R., Raaschou, N.T. and Naslund, I. (1991) Fine-Needle Aspiration Biopsy with a New Automatic Fine Needle Gun versus Histological Core in Ultrasonically-Guided Transrectal Biopsy for Detection of Prostate Cancer. Acta Oncoligica, 30, 155-157.
https://doi.org/10.3109/02841869109092340
[25]
Norberg, M., Busch, C., Stavinoha, J., Scardino, P.T. and Magnusson, A. (1994) Transrectal Ultrasound-Guided Core Biopsies of the Prostate: A Comparison between the Standard 1,2-mm Needle and Three Thinner Needles. Acta Radiologica, 35, 463-465. https://doi.org/10.1177/028418519403500514
[26]
Brock, M., Eggert, T., Palisaar, R.J., Roghmann, F., Braun, K., Loppenberg, B., et al. (2012) Multiparametric Ultrasound of the Prostate: Adding Contrast Enhanced Ultrasound to Real-Time Elastography to Detect Histopathologically Confirmed Cancer. Journal of Urology, 189, 93-98. https://doi.org/10.1016/j.juro.2012.08.183
[27]
Ferguson, R.S. (1930) Prostatic Neoplasms: Their Diagnosis by Needle Puncture and Aspiration. The American Journal of Surgery, 9, 507-511.
https://doi.org/10.1016/0002-9610(30)90126-2
[28]
Salomon, L., Azria, D., Bastide, C., Beuzeboc, P., Cormier, L., Cornud, F., et al. (2010) Recommandations en onco-urologie 2010: Cancer de la prostate. Progrès en Urologie, 20, 217-251. https://doi.org/10.1016/S1166-7087(10)70042-7
[29]
Salomon, L., et al. (2013) Recommandations en onco-urologie 2013 du CCAFU: Cancer de la prostate. Progrès en Urologie, 2, 69-102.
https://doi.org/10.1016/S1166-7087(13)70048-4
[30]
American Cancer Society (1989) Survey of Physician’s Attitudes and Practices in Early Cancer Detection. CA: A Cancer Journal for Clinicians, 40, 77-80.
https://doi.org/10.3322/canjclin.40.2.77
[31]
Hammerer, P. and Huland, H. (1994) Systematic Sextant Biopsies in 651 Patients Referred for Prostate Evaluation. Journal of Urology, 151, 99-102.
https://doi.org/10.1016/S0022-5347(17)34880-2
[32]
Mongiat-Artus, P. and Teillac, P. (2016) Screening for Prostate Cancer: Synthesis. Annales d’Urologie, 40, 106-110. https://doi.org/10.1016/j.anuro.2006.01.009
[33]
Yamamoto, T., Itio, K., Ohio, M., et al. (2001) Diagnostic Significance of Digital Rectal Examination and Transrectal Ultrasonography in Men with Prostate Specific Antigen Level of 4 ng/ml or Less. Urology, 58, 994-998.
https://doi.org/10.1016/S0090-4295(01)01409-1
